Liver tumor ablation: percutaneous and open approaches.
The global incidence of liver cancer is greater than a million cases a year. Surgical resection where applicable is still the standard of care for these patients. Various liver-directed regional therapies have been developed in an effort to treat the vast majority of unresectable liver tumors. This article reviews the principles behind various ablation therapies currently available for malignant liver tumors and their outcomes.
Padma
Srikanth
S
Section of Hepato-Pancreatico-Biliary Surgery, Division of GI & Minimally Invasive Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, North Carolina 28203, USA.
Martinie
John B
JB
Iannitti
David A
DA
D055011:Ablation Techniques / Q000379:methods*; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods; D003452:Cryosurgery / Q000379:methods; D000431:Ethanol / Q000008:administration & dosage; D057086:High-Intensity Focused Ultrasound Ablation / Q000379:methods; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D008872:Microwaves / Q000627:therapeutic use; D009367:Neoplasm Staging; D016896:Treatment Outcome
D000431:Ethanol